All happiness depends on a leisurely breakfast.

John Gunther

What is obese?

Fat distribution can influence a person's risk of disease. Fat carried around the waist and in the abdominal area, characterized by the "apple shape", is associated with an increased risk for many medical problems such as heart disease, cancer, high blood pressure, and diabetes. Fat that is mostly distributed around the buttocks and thighs is associated with a lower risk of developing these diseases.

Research points to differences in appetite control and energy expenditure. It is important for obese people not to hold themselves responsible for their condition.

To achieve lasting weight loss, commitment must be given to making real changes in eating patterns. Individuals are who not committed will gain back their weight.

During the holidays or when celebrating, many of us have overeaten. But some people have problems controlling their appetite and end up eating non-stop until eating is interrupted.

Binge eating is like bulimia, but does not include purging behaviors. A diagnosis of binge-eating disorder is made when a person binges an average of two days per week over a six month period.

Binge eating can be difficult to control because many people turn to food as a way of dealing with their feelings. Keeping a food diary can be beneficial in identifying specifically what feelings are likely to trigger binge eating as well as what types of foods are consumed during a binge. Strategies can then be employed to reduce the urge to binge when the impulse strikes.

Fat blocker drugs

The most recent drug in the fight against obesity is Xenical. A new class of non-systemic anti-obesity drug called lipase inhibitors which act in the gastrointestinal tract to prevent the absorption of fat by about 30 percent. Drugs in this class do not achieve their effect through brain chemistry or central nervous system stimulation. In other words, Xenical is not an appetite suppressant or metabolic inducer.

Brand names of the most effective prescription diet medications on the market today are: Phentermine, Adipex-P, Fastin, Ionamin, Bontril, Plegine, Tenuate, Xenical.

People respond differently to appetite suppressant medications, and some people experience more weight loss than others. Some obese patients using medication lose more than 10 percent of their starting body weight- an amount of weight loss that may reduce risk factors for obesity - related diseases, such as high blood pressure or diabetes.

Over the short term, weight loss in obese individuals may reduce a number of health risks. Studies looking at the effects of appetite suppressant medication treatment on obesity-related health risks have found that some agents lower blood pressure, blood cholesterol, triglycerides (fats) and decrease insulin resistance (the body's inability to use blood sugar) over the short term. Long-term studies are currently being done to determine if weight loss from appetite suppressant medications can improve health.

When considering long-term appetite suppressant medication treatment for obesity, you should consider the following areas of concern and potential risks. Currently, all prescription medications to treat obesity are controlled substances, meaning doctors need to follow certain restrictions when prescribing appetite suppressant medications. Although abuse and dependence are not common with non-amphetamine appetite suppressant medications, doctors should be cautious when they prescribe these medications for patients with a history of alcohol or other drug abuse.

Obesity often is viewed as the result of a lack of willpower, weakness, or a lifestyle "choice" - the choice to overeat and under exercise. The belief that persons choose to be obese adds to the hesitation of health professionals and patients to accept the use of long-term appetite suppressant medication treatment to manage obesity.

Because appetite suppressant medications are used to treat a condition that affects million of people, many of whom are basically healthy, their potential for side effects is of great concern. Most side effects of these medications are mild and usually improve with continued treatment.

Terms interpreting

FDA

• Food and Drug Administration: A government agency that oversees public safety in relation to drugs and medical devices. The FDA gives approval to pharmaceutical companies for commercial marketing of their products.

Fat blocker

• Drugs that block the absorption of fat or calories, and lose substantial weight.

Overweight

• Weighing more than is normal, necessary, or allowed, especially having more body weight than is considered normal or healthy for one's age or build.

Appetite

• An instinctive physical desire, especially one for food or drink. Decreased desire to eat is termed anorexia, while polyphagia (or "hyperphagia") is increased eating. Disregulation of appetite contributes to anorexia nervosa and cachexia, or oppositely, overeating.

Diabetes

• Any of several metabolic disorders marked by excessive discharge of urine and persistent thirst, especially one of the two types of diabetes mellitus.

Diet

• A regulated selection of foods, as for medical reasons or cosmetic weight loss.


• A solutions designed to reduce or suppress the appetite.

Fat

• Any of various soft, solid, or semisolid organic compounds constituting the esters of glycerol and fatty acids and their associated organic groups.

Obesity

• The condition of being obese; increased body weight caused by excessive accumulation of fat.

Stress

• A state of extreme difficulty, pressure, or strain.


• A physical and psychological response that results from being exposed to a demand or pressure.

Suppress

• To curtail or prohibit the activities of.


• To inhibit the expression of (an impulse, for example).


• To bring to an end forcibly as if by imposing a heavy weight.

Want show your work? Share ideas? Special art site ready for you.